Français
ItalianoBond AbbVie 0.597% ( US00287YBT55 ) in USD
| Issuer | AbbVie | ||||||||||||||||||||||||||
| Market price | 100 % ⇌ | ||||||||||||||||||||||||||
| Country |  United States
|
||||||||||||||||||||||||||
| ISIN code |
 US00287YBT55 ( in USD )
|
||||||||||||||||||||||||||
| Interest rate | 0.597% per year ( payment 4 times a year) | ||||||||||||||||||||||||||
| Maturity | 05/20/2021 - Bond has expired | ||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||||||||||||||
| Total amount | 750 000 000 USD | ||||||||||||||||||||||||||
| Cusip | 00287YBT5 | ||||||||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | ||||||||||||||||||||||||||
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) | ||||||||||||||||||||||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YBT55, pays a coupon of 0.597% per year. The coupons are paid 4 times per year and the Bond maturity is 05/20/2021 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YBT55, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YBT55, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
